Inventor · disambiguated record
Anette Henriksen
Also filed as: HENRIKSEN ANETTE
10 granted patents·6 pending applications·85 citations·filing 2012–2024
88Inventor score
Top patents by PatentIndex Score
16 records- 0195US8981061B2Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereofNOVO NORDISK AS·Filed 2012·Granted Mar 17, 2015·41 cites·2 claims
- 0293US9000127B2Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)NOVO NORDISK AS·Filed 2012·Granted Apr 7, 2015·23 cites·14 claims
- 0392US9550830B2Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)NOVO NORDISK AS·Filed 2013·Granted Jan 24, 2017·12 cites·8 claims
- 0485US11780910B1Anti-ANGPTL3 antibodies suitable for high concentration compositions and subcutaneous administrationNOVO NORDISK AS·Filed 2023·Granted Oct 10, 2023·1 cites·24 claims
- 0585US10189904B2Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)NOVO NORDISK AS·Filed 2016·Granted Jan 29, 2019·2 cites·14 claims
- 0685US10179814B2Site directed mutagenesis of TREM-1 antibodies for decreasing viscosityNOVO NORDISK AS·Filed 2015·Granted Jan 15, 2019·4 cites·21 claims
- 0785US2025034249A1Site directed mutagenesis of trem-1 antibodies for decreasing viscosityNOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 0884US10906975B2Methods of treating autoimmune disease or chronic inflammation with antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)NOVO NORDISK AS·Filed 2018·Granted Feb 2, 2021·2 cites·2 claims
- 0976US12116408B2Site directed mutagenesis of TREM-1 antibodies for decreasing viscosityNOVO NORDISK AS·Filed 2021·Granted Oct 15, 2024·0 cites·11 claims
- 1073US11858992B2Nucleic acids encoding antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)NOVO NORDISK·Filed 2021·Granted Jan 2, 2024·0 cites·8 claims
- 1170US2024043516A1Novel anti-angptl3 antibodies suitable for high concentration compositions and subcutaneous administrationNOVO NORDISK AS·Filed 2023·Application pending·0 cites
- 1268US11072654B2Site directed mutagenesis of TREM-1 antibodies for decreasing viscosityNOVO NORDISK AS·Filed 2018·Granted Jul 27, 2021·0 cites·17 claims
- 1356US2017320946A1Receptor trem (triggering receptor expressed on myeloid cells) and uses thereofNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 1451US2016251434A1Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereofNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 1551US2015273027A1Liquid pharmaceutical composition of factor vii polypeptideNOVO NORDISK HEALTHCARE AG·Filed 2013·Application pending·0 cites
- 1645US2015274825A1Antibodies that Bind and Block Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1)NOVO NORDISK AS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anette Henriksen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →